ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.3605
-0.0160 (-4.25%)
At close: Apr 1, 2025, 4:00 PM
0.3624
+0.0019 (0.53%)
After-hours: Apr 1, 2025, 7:46 PM EDT

ImmunoPrecise Antibodies Ratios and Metrics

Millions USD. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20 2019 - 2015
Market Capitalization
16346413118738
Upgrade
Market Cap Growth
-67.25%-47.50%-50.98%-30.05%386.87%-4.92%
Upgrade
Enterprise Value
16406110717840
Upgrade
Last Close Price
0.381.282.575.569.762.77
Upgrade
PS Ratio
0.651.894.218.6612.873.80
Upgrade
PB Ratio
0.711.371.512.234.053.54
Upgrade
P/TBV Ratio
1.4017.2911.267.205.35-
Upgrade
EV/Sales Ratio
0.992.234.027.0912.223.96
Upgrade
Debt / Equity Ratio
0.520.400.130.040.060.30
Upgrade
Asset Turnover
0.390.360.240.240.380.51
Upgrade
Inventory Turnover
5.305.944.955.956.437.54
Upgrade
Quick Ratio
1.990.982.143.597.560.80
Upgrade
Current Ratio
2.321.412.844.038.050.97
Upgrade
Return on Equity (ROE)
-124.75%-59.26%-39.91%-25.28%-20.39%-29.84%
Upgrade
Return on Assets (ROA)
-14.88%-12.78%-18.33%-13.04%-8.83%-9.18%
Upgrade
Return on Capital (ROIC)
-18.07%-15.63%-21.96%-15.12%-10.40%-12.61%
Upgrade
Earnings Yield
-196.04%-58.70%-30.53%-9.96%-3.19%-9.27%
Upgrade
FCF Yield
-40.17%-12.19%-24.51%-6.55%-0.88%-3.47%
Upgrade
Buyback Yield / Dilution
-13.69%-2.97%-26.46%-19.51%-20.88%-8.67%
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q